Ye Xu

2.9k total citations
77 papers, 2.5k citations indexed

About

Ye Xu is a scholar working on Molecular Biology, Cell Biology and Epidemiology. According to data from OpenAlex, Ye Xu has authored 77 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 20 papers in Cell Biology and 19 papers in Epidemiology. Recurrent topics in Ye Xu's work include Endoplasmic Reticulum Stress and Disease (18 papers), Autophagy in Disease and Therapy (18 papers) and Nanoparticle-Based Drug Delivery (8 papers). Ye Xu is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (18 papers), Autophagy in Disease and Therapy (18 papers) and Nanoparticle-Based Drug Delivery (8 papers). Ye Xu collaborates with scholars based in China, Saint Kitts and Nevis and Mexico. Ye Xu's co-authors include Liankun Sun, Jing Su, Jinsong Kang, Huimei Yu, Zhan‐You Wang, Xu Wang, Chunyan Wang, Hongyan Li, Chunyan Yu and Xiyan Xiang and has published in prestigious journals such as ACS Nano, PLoS ONE and Biomaterials.

In The Last Decade

Ye Xu

74 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ye Xu China 32 1.3k 476 307 282 276 77 2.5k
Jung Jin Hwang South Korea 27 1.4k 1.1× 599 1.3× 209 0.7× 252 0.9× 259 0.9× 75 2.7k
Zhenyu Yin China 32 1.8k 1.4× 520 1.1× 251 0.8× 635 2.3× 515 1.9× 87 3.2k
Xiaoyan Sun China 29 1.7k 1.3× 268 0.6× 285 0.9× 438 1.6× 346 1.3× 76 2.7k
Qihua He China 32 1.4k 1.1× 189 0.4× 223 0.7× 241 0.9× 473 1.7× 111 3.1k
Kyung Hee Jung South Korea 35 1.5k 1.2× 401 0.8× 116 0.4× 343 1.2× 584 2.1× 125 3.5k
Peng Zhao China 33 1.5k 1.2× 825 1.7× 302 1.0× 513 1.8× 339 1.2× 97 3.4k
Joana D. Amaral Portugal 28 1.1k 0.9× 453 1.0× 217 0.7× 210 0.7× 631 2.3× 52 2.7k
Lang Zhuo China 23 879 0.7× 306 0.6× 143 0.5× 203 0.7× 107 0.4× 58 2.3k
Clara De Palma Italy 32 1.4k 1.1× 332 0.7× 232 0.8× 132 0.5× 120 0.4× 66 2.5k
Jianhong Zhu China 30 1.4k 1.1× 243 0.5× 93 0.3× 368 1.3× 241 0.9× 78 2.5k

Countries citing papers authored by Ye Xu

Since Specialization
Citations

This map shows the geographic impact of Ye Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Xu more than expected).

Fields of papers citing papers by Ye Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Xu. The network helps show where Ye Xu may publish in the future.

Co-authorship network of co-authors of Ye Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ye Xu. A scholar is included among the top collaborators of Ye Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Xu. Ye Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhan, Shoubin, Ye Xu, Botao Li, et al.. (2025). Landscape of extracellular small RNA and identification of biomarkers in multiple human cancers. iScience. 28(8). 113098–113098.
2.
Xu, Ye, et al.. (2025). Polarization standard filtering enables multi-attribute tobacco grading by near-infrared spectroscopy. Analytica Chimica Acta. 1377. 344676–344676.
4.
He, Lili, et al.. (2023). Comparative dosimetric study of radiotherapy in high-grade gliomas based on the guidelines of EORTC and NRG-2019 target delineation. Frontiers in Oncology. 13. 1108587–1108587. 1 indexed citations
5.
Zhang, Jun, Yanfei Deng, Yun Feng, et al.. (2021). Transforming Growth Factor-β1 Enhances Mesenchymal Characteristics of Buffalo ( Bubalus bubalis ) Bone Marrow-Derived Mesenchymal Stem Cells. Cellular Reprogramming. 23(2). 127–138. 2 indexed citations
6.
Zhang, Jun, Mengjia Chen, Xi Yan, et al.. (2021). Hypoxia promotes steroidogenic competence of buffalo (Bubalus bubalis) theca cells. Theriogenology. 180. 113–120. 4 indexed citations
7.
Wang, Chunyan, Ye Xu, Xu Wang, et al.. (2018). Dl-3-n-Butylphthalide Inhibits NLRP3 Inflammasome and Mitigates Alzheimer's-Like Pathology via Nrf2-TXNIP-TrX Axis. Antioxidants and Redox Signaling. 30(11). 1411–1431. 160 indexed citations
8.
Xu, Lu, Qi Ling, Hongyan Tian, et al.. (2017). BMH-21 inhibits viability and induces apoptosis by p53-dependent nucleolar stress responses in SKOV3 ovarian cancer cells. Oncology Reports. 38(2). 859–865. 16 indexed citations
9.
Xie, Qi, Jing Su, Luyan Shen, et al.. (2016). ABT737 reverses cisplatin resistance by regulating ER-mitochondria Ca2+ signal transduction in human ovarian cancer cells. International Journal of Oncology. 49(6). 2507–2519. 46 indexed citations
10.
Wang, Chunyan, Zhan‐You Wang, Jingwei Xie, et al.. (2015). Dl-3-n-butylphthalide-induced upregulation of antioxidant defense is involved in the enhancement of cross talk between CREB and Nrf2 in an Alzheimer's disease mouse model. Neurobiology of Aging. 38. 32–46. 69 indexed citations
11.
Huang, Zhen, Ye Xu, & Wei Peng. (2015). Colchicine induces apoptosis in HT-29 human colon cancer cells via the AKT and c-Jun N-terminal kinase signaling pathways. Molecular Medicine Reports. 12(4). 5939–5944. 45 indexed citations
12.
Lin, Gan, Wencheng Zhu, Li Yang, et al.. (2014). Delivery of siRNA by MRI-visible nanovehicles to overcome drug resistance in MCF-7/ADR human breast cancer cells. Biomaterials. 35(35). 9495–9507. 67 indexed citations
13.
Wang, Chunyan, Zhan‐You Wang, Jingwei Xie, et al.. (2014). CD36 Upregulation Mediated by Intranasal LV-NRF2 Treatment Mitigates Hypoxia-Induced Progression of Alzheimer's-Like Pathogenesis. Antioxidants and Redox Signaling. 21(16). 2208–2230. 46 indexed citations
14.
Xia, Meihui, Huimei Yu, Shuang Gu, et al.. (2014). p62/SQSTM1 is involved in cisplatin resistance in human ovarian cancer cells via the Keap1-Nrf2-ARE system. International Journal of Oncology. 45(6). 2341–2348. 64 indexed citations
15.
Xu, Ye, Chunyan Wang, & Zhixin Li. (2013). A new strategy of promoting cisplatin chemotherapeutic efficiency by targeting endoplasmic reticulum stress. Molecular and Clinical Oncology. 2(1). 3–7. 54 indexed citations
16.
Wang, Chunyan, Tao Wang, Ye Xu, et al.. (2013). Hypoxia‐Triggered m‐Calpain Activation Evokes Endoplasmic Reticulum Stress and Neuropathogenesis in a Transgenic Mouse Model of Alzheimer's Disease. CNS Neuroscience & Therapeutics. 19(10). 820–833. 36 indexed citations
17.
Wang, Chunyan, Jingwei Xie, Ye Xu, et al.. (2013). Trientine Reduces BACE1 Activity and Mitigates Amyloidosis via the AGE/RAGE/NF-κB Pathway in a Transgenic Mouse Model of Alzheimer's Disease. Antioxidants and Redox Signaling. 19(17). 2024–2039. 55 indexed citations
18.
Zhong, Jiateng, Ye Xu, Haowei Yi, et al.. (2012). The BH3 mimetic S1 induces autophagy through ER stress and disruption of Bcl-2/Beclin 1 interaction in human glioma U251 cells. Cancer Letters. 323(2). 180–187. 50 indexed citations
19.
Yu, Chunyan, Xiaowei Huang, Ye Xu, et al.. (2012). Lysosome Dysfunction Enhances Oxidative Stress‐Induced Apoptosis through Ubiquitinated Protein Accumulation in Hela Cells. The Anatomical Record. 296(1). 31–39. 38 indexed citations
20.
Xu, Ye, Huimei Yu, Hanjiao Qin, et al.. (2011). Inhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in human cervical cancer cells. Cancer Letters. 314(2). 232–243. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026